2020
DOI: 10.1007/s00246-020-02463-3
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic Accuracy and Safety of Confirm Rx™ Insertable Cardiac Monitor in Pediatric Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 10 publications
1
3
0
Order By: Relevance
“…Mariani et al [ 3 ] reported a mean R wave amplitude of 0.7 ± 0.37 mV with a median noise burden of 0.19% and good P wave visibility (89 ± 24%) after a mean follow-up period of 35.2 ± 18.5 days. Furthermore, our results appear to be satisfactory in light of recent reports in the literature evaluating the performance of other currently available next-generation ILRs in pediatric patients [ 14 16 ].…”
Section: Discussionsupporting
confidence: 76%
“…Mariani et al [ 3 ] reported a mean R wave amplitude of 0.7 ± 0.37 mV with a median noise burden of 0.19% and good P wave visibility (89 ± 24%) after a mean follow-up period of 35.2 ± 18.5 days. Furthermore, our results appear to be satisfactory in light of recent reports in the literature evaluating the performance of other currently available next-generation ILRs in pediatric patients [ 14 16 ].…”
Section: Discussionsupporting
confidence: 76%
“…Nevertheless, experimental and observational studies have demonstrated the potential for implementation in children experiencing loss of consciousness of unknown cause. The aim is to exclude or confirm potentially dangerous underlying arrhythmias [30][31][32][33][34][35][36].…”
Section: Guideline-based Indications For Ilr In Syncopementioning
confidence: 99%
“…The enhancements in the ILR algorithm were prompted by a higher rate of FP detection in the earlier studies [13,20,21]. Data for Confirm Rx TM in pediatric patients showed a reduction of FP from 55% to 0 with introduction of newer algorithms in a small number of patients receiving SCRM for variable indications [22]. A similar algorithm is used in other SCRMs [23].…”
Section: Af Diagnosticsmentioning
confidence: 99%